KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cognex (CGNX) Research & Development (2016 - 2026)

Cognex filings provide 17 years of Research & Development readings, the most recent being $36.1 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 10.82% to $36.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $139.0 million, a 0.6% decrease, with the full-year FY2025 number at $139.0 million, down 0.6% from a year prior.
  • Research & Development hit $36.1 million in Q4 2025 for Cognex, up from $35.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $38.5 million in Q2 2023 to a low of $31.3 million in Q3 2021.
  • Median Research & Development over the past 5 years was $34.7 million (2023), compared with a mean of $34.7 million.
  • Biggest five-year swings in Research & Development: rose 14.01% in 2021 and later dropped 6.57% in 2023.
  • Cognex's Research & Development stood at $35.5 million in 2021, then grew by 4.64% to $37.1 million in 2022, then decreased by 6.57% to $34.7 million in 2023, then fell by 6.21% to $32.5 million in 2024, then rose by 10.82% to $36.1 million in 2025.
  • The last three reported values for Research & Development were $36.1 million (Q4 2025), $35.1 million (Q3 2025), and $33.1 million (Q2 2025) per Business Quant data.